AG-13958
Products
Description
AG-13958 (AG-013958), a VEGFR tyrosine kinase inhibitor, is in clinical development with ST administration for treatment of choroidal neovascularization associated with age–related macular degeneration (AMD).
Specifications
| Manufacturer Cat# | S2211 |
|---|---|
| Target | VEGFR |